PELISH HENRY E. (Chief Scientific Officer) sold 4.5% of their position (3.09K shares) of NUVALENT, INC. on the open market
Open‑market sale worth $323.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/13/2026ACC: 0002029477-26-000004
Officer· Chief Scientific Officer
Since Mar 2026
-3.09K
Net shares
Net seller
$323.2K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
3.09K acquired · 6.19K disposed
Non-Derivative Transactions3
Class A Common Stock
Direct
Shares
+3.09K
Price / share
$27.85
Trade value
$86.14K
% of position
4.7%
4/9/2026
65.60K→68.70K
Class A Common Stock
Direct
Shares
−2.19K
Price / share
$104.27
Trade value
$228.66K
% of position
3.2%
4/9/2026
68.70K→66.50K
Class A Common Stock
Direct
Shares
−900.00
Price / share
$105.00
Trade value
$94.50K
% of position
1.4%
4/9/2026
66.50K→65.60K
Total
Net shares
+0.00
Net value
-$237.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 4/9/2026 | M · Option Exercise | +3.09K | $27.85 | $86.14K | 4.7% | 65.60K | 68.70K |
| Class A Common Stock Direct | 4/9/2026 | S · Sale | −2.19K | $104.27 | $228.66K | 3.2% | 68.70K | 66.50K |
| Class A Common Stock Direct | 4/9/2026 | S · Sale | −900.00 | $105.00 | $94.50K | 1.4% | 66.50K | 65.60K |
| Total | +0.00 | -$237.02K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Class A Common Stock
3.09K shares
Shares
−3.09K
Strike price
27.85
Held after
8.31K
Exercisable
—
4/9/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Class A Common Stock3.09K shares | 4/9/2026 | M · Option Exercise | −3.09K | 27.85 | — | 8.31K |